UMB Bank, n.a. - AERIE PHARMACEUTICALS INC ownership

AERIE PHARMACEUTICALS INC's ticker is AERI and the CUSIP is 00771V108. A total of 152 filers reported holding AERIE PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is 0.08 and the average weighting 0.1%.

Quarter-by-quarter ownership
UMB Bank, n.a. ownership history of AERIE PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2021$160,000
-10.6%
10,0000.0%0.00%0.0%
Q1 2021$179,000
+32.6%
10,0000.0%0.00%0.0%
Q4 2020$135,000
-9.4%
10,000
-0.9%
0.00%
-20.0%
Q3 2020$149,0000.0%10,0900.0%0.01%0.0%
Q2 2020$149,000
+9.6%
10,090
-0.1%
0.01%0.0%
Q1 2020$136,000
-44.5%
10,1050.0%0.01%
-28.6%
Q4 2019$245,000
+26.3%
10,1050.0%0.01%
+40.0%
Q3 2019$194,000
-35.1%
10,1050.0%0.01%
-28.6%
Q2 2019$299,00010,1050.01%
Other shareholders
AERIE PHARMACEUTICALS INC shareholders Q4 2020
NameSharesValueWeighting ↓
LEVIN CAPITAL STRATEGIES, L.P. 1,373,542$15,658,0001.56%
DAFNA Capital Management LLC 289,040$3,295,0000.87%
Integral Health Asset Management, LLC 250,000$2,850,0000.82%
JACOB ASSET MANAGEMENT OF NEW YORK LLC 193,266$2,203,0000.80%
PFM Health Sciences, LP 2,182,684$24,883,0000.73%
DCF Advisers, LLC 136,501$1,556,0000.69%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 2,977,020$33,938,0000.66%
NEXPOINT ASSET MANAGEMENT, L.P. 309,778$3,532,0000.61%
Rhenman & Partners Asset Management AB 750,000$8,550,0000.60%
RICE HALL JAMES & ASSOCIATES, LLC 1,232,600$14,052,0000.52%
View complete list of AERIE PHARMACEUTICALS INC shareholders